Overview

Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

Status:
Completed
Trial end date:
2018-02-13
Target enrollment:
0
Participant gender:
Female
Summary
A prospective, double blinded and randomized study included women with breast cancer and underwent mastectomy, and randomly allocated into two groups of equal size. Lidocaine group and control group.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- Women aged between 18 and 60 years old with breast cancer and underwent mastectomy,
American society of Anesthesiologist I or II

Exclusion Criteria:

- Patients with contralateral breast cancer, metastatic tumor, morbid obesity (BMI> 40),
allergy to an amide local anesthetic, or morphine sulphate, heart block, renal, or
liver dysfunction, or substance abuse disorder, or chronic opioid use